Dynavax Technologies | DVAX - 债务



债务 更改 日
AbbVie USD 1000K 70.48B 2025-09
Adma Biologics USD 83.12M 702K 2025-09
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
Merck USD 41.37B 5.97B 2025-09
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.64B 1.37B 2025-06
Pfizer USD 60.85B 78M 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
TG Therapeutics USD 245.34M 8.38M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09